FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.3120
-0.0074 (-2.32%)
May 9, 2025, 11:18 AM - Market open
FibroGen Employees
FibroGen had 225 employees as of December 31, 2024. The number of employees decreased by 261 or -53.70% compared to the previous year.
Employees
225
Change (1Y)
-261
Growth (1Y)
-53.70%
Revenue / Employee
$131,649
Profits / Employee
-$211,462
Market Cap
31.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FGEN News
- 1 day ago - Duchenne Muscular Dystrophy (DMD) Pipeline Insight Report 2025, Featuring Analysis of Vamorolone (Santhera), Givinostat (Italfarmaco), and Pamrevlumab (Fibrogen) - GlobeNewsWire
- 3 days ago - FibroGen to Report First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - FibroGen, Inc. (FGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - Benzinga
- 2 months ago - FibroGen sells China unit to AstraZeneca in deal worth $160 million - Reuters